Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 73

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 73
---
 Dunn and Morgan Stanley, respectively, to discuss certain open issues in the merger agreement.

Thereafter until the signing of the Merger Agreement on August 4, 2025, Wachtell Lipton and Gibson Dunn exchanged drafts of the merger
agreement and confidential disclosure schedules and the parties continued to negotiate the terms of the transaction.

At various times
from July 23 through August 1, 2025, Mr. Farrell, Warren Foust, STAAR’s President and Chief Operating Officer, and Ms. Andrews engaged in calls with representatives of Stockholder A to discuss STAAR’s financial
performance and Stockholder A’s views regarding STAAR’s potential future performance and standalone value.

From July 31,
2025 and through August 4, 2025, STAAR’s and Alcon’s respective management teams, with the assistance of their respective legal advisors, worked to finalize the remaining open issues related to the merger agreement and related
transaction documents. In addition, Mr. Farrell and Mr. Endicott from time to time discussed certain terms and open legal points in the merger agreement, including (i) the purchase price for each share of STAAR common stock,
(ii) the terms of the “window shop” and amounts of termination fees that would be payable by STAAR to Alcon in certain circumstances, (iii) no termination fee payable by STAAR if its stockholders did not approve the merger and
(iv) covenants related to regulatory approvals. Mr. Endicott indicated a willingness to resolve the open items in the merger agreement but noted that Alcon was unwilling to increase the offer price above $28.00 per share.

On August 2, 2025, the Board met with members of STAAR’s management with representatives of Citi and Wachtell Lipton in attendance.
Members of STAAR’s management provided an update on the status of negotiations with Alcon, including Mr. Endicott’s indication that Alcon would not be willing to increase its offer price. Mr. Farrell provided an overview of his
discussions with representatives of Stockholder A, including that Stockholder A continued to expect STAAR to grow at a rate higher than management’s expected growth for STAAR, and that Stockholder A may seek to vote down or to otherwise
prevent the consummation of the Merger. The directors discussed STAAR’s business and prospects, and reviewed the Projections (as defined in “The Merger—Certain Unaudited Prospective Financial Information”), which were